What to expect from PEGS Europe 2023: Day 2
Drug Discovery World
NOVEMBER 9, 2023
Engineering for higher avidity and multi-valency Following chairperson’s remarks from Bruce Keyt, PhD, CSO, R&D, IGM Biosciences, there will be three presentations in this session. James Cooke, PhD, Associate Director, Bicycle Therapeutics, on: ‘Engineering bicyclic peptides for precision targeted medicine’.
52 
Let's personalize your content